Birbal S. Bhaskar

Oncology
1100 W Stewart Dr Fl 2
Orange, CA 92868

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma.

Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma.

Journal: Cancer
Published: April 30, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026